SMS PHARMACEUTICALS
Back to Balance Sheet
|
SMS PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹166 Cr | ₹164 Cr | ₹193 Cr | ₹206 Cr | ₹114 Cr |
What is the latest Total Non-Current Liabilities ratio of SMS PHARMACEUTICALS ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹166 Cr |
Mar2023 | ₹164 Cr |
Mar2022 | ₹193 Cr |
Mar2021 | ₹206 Cr |
Mar2020 | ₹114 Cr |
How is Total Non-Current Liabilities of SMS PHARMACEUTICALS Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹166 Cr | 1.14 | |
Mar2023 | ₹164 Cr | -14.82 | |
Mar2022 | ₹193 Cr | -6.56 | |
Mar2021 | ₹206 Cr | 80.18 | |
Mar2020 | ₹114 Cr | - |
Compare Total Non-Current Liabilities of peers of SMS PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SMS PHARMACEUTICALS | ₹1,799.9 Cr | -1.4% | -4.8% | 36.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,363.0 Cr | -2.8% | -3.6% | 10.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹158,396.0 Cr | -2.5% | 1.5% | 59.1% | Stock Analytics | |
CIPLA | ₹117,088.0 Cr | -1.5% | 0.2% | 1.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,458.0 Cr | -1.6% | -9.2% | -4.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹94,002.4 Cr | -7.4% | -5.1% | 9.9% | Stock Analytics |
SMS PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SMS PHARMACEUTICALS | -1.4% |
-4.8% |
36.5% |
SENSEX | -2.7% |
-0.4% |
6.4% |
You may also like the below Video Courses